Serial Number | 97405280 |
Word Mark | ADPL |
Filing Date | Wednesday, May 11, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, September 5, 2023 |
Registration Number | 7154375 |
Registration Date | Tuesday, September 5, 2023 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 20, 2023 |
Goods and Services | A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, May 17, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Mercury Pharma Group Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | London EC4N7BL GB |
Party Name | Mercury Pharma Group Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | London EC4N7BL GB |
Party Name | Mercury Pharma Group Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | London EC4N7BL GB |
Event Date | Event Description |
Tuesday, September 5, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, September 5, 2023 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, June 20, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 20, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, May 31, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, May 15, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Monday, May 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, May 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, May 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, May 4, 2023 | ASSIGNED TO LIE |
Thursday, February 2, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Tuesday, January 24, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, January 24, 2023 | LETTER OF SUSPENSION E-MAILED |
Tuesday, January 24, 2023 | SUSPENSION LETTER WRITTEN |
Tuesday, January 24, 2023 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, January 24, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, January 24, 2023 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, January 24, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, January 18, 2023 | ASSIGNED TO EXAMINER |
Tuesday, May 17, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, May 14, 2022 | NEW APPLICATION ENTERED |